SEK157.50
0.00% today
Stockholm, Feb 28, 05:29 pm CET
ISIN
SE0014428512
Symbol
SUS
Sector

Surgical Science Sweden AB Stock price

SEK157.50
-15.70 9.06% 1M
+30.10 23.63% 6M
+1.60 1.03% YTD
-2.80 1.75% 1Y
-54.50 25.71% 3Y
+84.50 115.75% 5Y
+128.90 450.70% 10Y
Stockholm, Closing price Thu, Feb 27 2025
-1.50 0.94%
ISIN
SE0014428512
Symbol
SUS
Sector

Key metrics

Market capitalization SEK8.04b
Enterprise Value SEK7.30b
P/E (TTM) P/E ratio 61.05
EV/Sales (TTM) EV/Sales 8.26
P/S ratio (TTM) P/S ratio 9.09
P/B ratio (TTM) P/B ratio 1.66
Revenue growth (TTM) Revenue growth 0.14%
Revenue (TTM) Revenue SEK884.09m
EBIT (operating result TTM) EBIT SEK149.40m
Cash position SEK968.16m
EPS (TTM) EPS SEK2.58
P/E forward 40.46
P/S forward 7.04
EV/Sales forward 6.40
Show more

Is Surgical Science Sweden AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Surgical Science Sweden AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Surgical Science Sweden AB forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Surgical Science Sweden AB forecast:

Buy
80%
Hold
20%

Financial data from Surgical Science Sweden AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
884 884
0% 0%
100%
- Direct Costs 345 345
6% 6%
39%
539 539
4% 4%
61%
- Selling and Administrative Expenses 153 153
5% 5%
17%
- Research and Development Expense 176 176
6% 6%
20%
210 210
15% 15%
24%
- Depreciation and Amortization 61 61
9% 9%
7%
EBIT (Operating Income) EBIT 149 149
22% 22%
17%
Net Profit 132 132
44% 44%
15%

In millions SEK.

Don't miss a Thing! We will send you all news about Surgical Science Sweden AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, offers a procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.

Head office Sweden
CEO Tom Englund
Employees 274
Founded 1997
Website www.surgical-science.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today